Tuo Deng

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy”.

Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy

PLoS ONE(2020)10.1371/journal.pone.0229754

N/A

0.639DataRank · unranked

12 citations

Tuo Deng, Xingbo Long, Xueming Lin, Shulin Wu, Hongbo Wang +6 more

MP37-02 METHYLATION OF SRD5A2 PROMOTER PREDICTS A BETTER OUTCOME FOR PATIENTS UNDERGOING ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER

The Journal of Urology(2020)10.1097/ju.0000000000000886.02

N/A

0DataRank · unranked

0 citations

Tuo Deng, Xueming Lin, Shulin Wu, Zhenwei Zhang, Chin‐Lee Wu +3 more